Truist Securities Initiates Coverage On Organogenesis Holdings with Hold Rating, Announces Price Target of $3

Benzinga Newsdesk www.benzinga.com Neutral 69.6%

Neg 0% Neu 69.6% Pos 0%

Truist Securities analyst Ravi Misra initiates coverage on Organogenesis Holdings (NASDAQ:ORGO) with a Hold rating and announces Price Target of $3.